Patient Support

Savings Card

Pay as little as $0 for a 1-month prescription of Humatrope. Month is defined as 30-days

Governmental beneficiaries excluded, terms and conditions apply^†.

^†Terms and Conditions

By enrolling in and using the Humatrope Savings Card Program (“Program”) and using the Humatrope Savings Card (“Card”), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility:

You have been prescribed Humatrope for an approved use consistent with FDA approved product labeling;
You are enrolled in a commercial drug insurance plan with coverage for Humatrope;
You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE^®/CHAMPUS, or any state prescription drug assistance program;
You are a resident of the United States or Puerto Rico; and
You are 18 years of age or older.

Card Terms and Conditions
For patients with commercial drug insurance coverage for Humatrope: You must have commercial drug insurance that covers Humatrope and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $0 for a 1-month prescription fill of Humatrope. Month is defined as 30-days. Card savings are subject to a maximum monthly savings of wholesale acquisition cost plus usual and customary pharmacy charges and separate maximum annual savings of up to $3,200 per calendar year. Card may be used for maximum of up to 12 prescription fills per calendar year. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2026.

Additional Program Terms and Conditions
If you have an insurance plan that is participating in an alternate funding program (“AFP”) that requires you to apply to the Humatrope Savings Card Program or otherwise pursue specialty drug prescription coverage through an alternate funding vendor as a condition of, requirement for, or prerequisite to coverage of Humatrope, you are not eligible for and are prohibited from using the Humatrope Savings Card Program. AFPs include programs where coverage, reimbursement, or patient out of pocket costs for a product in some way vary based on the availability of a manufacturer co-pay program. AFPs may modify, delay, deny, restrict, or withhold insurance benefits or coverage from patients, or exclude Lilly products from coverage contingent upon a member’s use of Humatrope Savings Card Program. You agree to inform Humatrope Savings Card Program if you are or become a member of such an alternative funding program. You are responsible for any applicable taxes, fees, and any amount that exceeds the monthly or annual maximum Card savings. Monthly and annual maximum savings are set at Lilly’s sole and absolute discretion and may be changed with or without notice at any time for any reason. At its sole discretion and with or without notice, Lilly may reduce, eliminate, or otherwise modify the Card savings for any reason, including but not limited to if your commercial drug insurance plan imposes additional requirements which limits or prevents you from receiving coverage for Humatrope, only allows partial coverage for Humatrope, removes coverage for Humatrope and requires you to utilize the Card, does not provide a material level of financial assistance for the cost of Humatrope, or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for Humatrope. Card savings are not valid for: Massachusetts residents if an AB-rated generic equivalent is available; California residents if an FDA-approved therapeutic equivalent is available. You must meet the Card eligibility criteria, terms and conditions every time you use the Card. If at any time you begin receiving drug coverage under any state, federal, or government funded healthcare program, you understand that you will no longer be eligible for the Humatrope Savings Card and agree to call the Humatrope Savings Card Program at 1-877-456-6837 to stop participation. Card activation is required. You may not seek reimbursement from your health insurance, any third party, or any health savings, flexible spending, or other healthcare reimbursement accounts, for any amount of the savings received through the Card. By utilizing the Card, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you will notify your Insurance Carrier of your redemption of the Card. Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Humatrope. You agree that this Card savings is intended solely for the benefit of you, the patient, and that the Card benefits are non-transferable. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade, or to counterfeit the Card. THIS CARD IS NOT INSURANCE. Lilly has the sole right to interpret and apply Card eligibility criteria, and terms and conditions. Card eligibility, and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Lilly’s sole discretion to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions includes the right to terminate any individual Card if Lilly determines, in its sole discretion, that a patient does not satisfy the Card’s eligibility criteria or is using or has attempted to use the Card inconsistently with these terms and conditions. Eligibility criteria, and terms and conditions for the Humatrope Savings Card Program may change from time to time; the most current version can be found at https://www.humatrope.lilly.com/patient-support. You may be required to obtain a new Card, including if any Card terms and conditions have been terminated, rescinded, revoked, or amended by Lilly. Card void where prohibited by law. Subject to Lilly’s right to terminate, rescind, revoke or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2026.

TRICARE^® is a registered trademark of the Department of Defense (DoD), DHA.

If you have any questions about the Humatrope Savings Card, please call 1-866-923-1953, Monday through Friday 8 AM - 8 PM Eastern time. This offer may be terminated, rescinded, revoked, or amended by Lilly USA, LLC at any time without notice.

^* Subject to usual and customary pharmacy changes.

Other Resources

Advocacy groups

Coping with therapy

Talking With Your Child About Therapy

You know your child better than anyone else, and talking often helps keep it that way. Throughout treatment, here are some tips to keep the conversation going.

Talk About Expectations. Keep your child involved from the start, and make sure you both know what to expect by talking with your healthcare professional. Kids who know what to expect from the start may have more of a reason to stick with their therapy.

Learn More Together. As you learn about growth and treatment, share what you discover with your child. This can help guide kids to the right kind of information, and help them feel more in control of their growth.

Keep Track of Questions. Answer questions as best you can, and write down questions you can't answer. Let your child ask the questions at the next doctor's visit — children may feel more in control if they understand what's going on.

Connect With Friends. Support groups throughout the country have programs focused on kids on a similar growth treatment journey, and they often meet once a year—giving you both a chance to learn more, connect with other families, and make new friends who can understand what you're going through.

SAFETY SUMMARY

Do not take Humatrope if you are having serious complications after having open heart surgery, abdominal surgery, or serious injuries involving many body systems, or are having life-threatening breathing problems. Deaths have been reported in such cases.

Do not use Humatrope in children with Prader-Willi syndrome who are severely obese or have a history of blocked upper airways or other severe breathing problems, or sleep apnea. Deaths have been reported in such cases. Humatrope is not approved for the treatment of patients with Prader-Willi syndrome.

Do not use Humatrope if you have active cancer. Growth hormone deficiency can be an early sign of some tumors in the brain or pituitary gland. The presence of these types of tumors should be ruled out by your doctor before you start Humatrope.

Serious allergic reactions have been reported with Humatrope. Humatrope is contraindicated if you know you have allergies to growth hormone or any of its ingredients. Tell your doctor if you have an allergic reaction. Do not mix Humatrope with the supplied diluent if you are allergic to metacresol or glycerin.

Your doctor should check your blood sugar regularly while you are taking Humatrope, especially if you have diabetes, pre-diabetes, or risk factors for diabetes. New cases of type 2 diabetes have been reported in patients taking Humatrope.

Tell your doctor if you have any visual changes accompanied by headache, nausea, and/or vomiting while taking Humatrope. This may be a sign of increased pressure in the brain.

Adults may retain water during Humatrope treatment. This may be brief and may increase with higher doses of Humatrope.

If you have hypoadrenalism and are on glucocorticoid replacement therapy, your doctor may increase your dosage when you initiate growth hormone treatment.

Your doctor should test your thyroid function periodically during Humatrope therapy. Thyroid hormone treatment may need to be started or adjusted.

Fracture in the ball of the hip joint can occur in children who have endocrine problems and in children who have rapid growth. Some pediatric patients taking Humatrope for short height developed a fracture in the ball of hip joint with or without osteonecrosis. Any child taking Humatrope who develops a limp or complains of hip or knee pain should be seen by a doctor to check for fracture in the ball of the hip joint and osteonecrosis and managed accordingly.

Progression of curvature of the spine (scoliosis) can occur in children who have rapid growth. Humatrope has not been shown to increase the occurrence of this condition. If the child has scoliosis, the doctor should carefully monitor the progression of the scoliosis during Humatrope treatment.

Cases of pancreatitis (inflammation of the pancreas) have been reported rarely in children and adults receiving growth hormone. Consult a doctor if you develop abdominal pain while taking Humatrope.

You should rotate your injection sites to avoid breakdown of skin and fat. Seek prompt medical attention for any allergic reaction you experience to the injection of Humatrope.

Who should not take Humatrope?

Humatrope should not be used by:

People with serious complications after having open heart surgery, abdominal surgery, serious injuries involving many body systems, or with life-threatening breathing problems
Children with Prader-Willi syndrome who are severely obese or have a history of severe breathing problems
People with active cancer
People who have had an allergic reaction to growth hormone
People with diabetic disease of the retina (the lining in the back of the eyeball)
Children who have closed growth plates in their bones

What should I tell my doctor before taking Humatrope?

Tell your doctor about all of your prescription and over the counter drugs, including cyclosporine, hormone replacement therapy, insulin or other diabetes medications, drugs containing steroids, or drugs for seizures. These medications may need to be adjusted while taking Humatrope.

What are the possible side effects of Humatrope?

Common side effects reported in adults and children taking Humatrope include upper respiratory infection, fever, throat inflammation, headache, inner ear inflammation, swelling, joint pain, unusual skin sensations, muscle pain, carpal tunnel syndrome, leg swelling, flu syndrome, low thyroid, and high blood sugar.

You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How should I store Humatrope?

Humatrope must be kept refrigerated (36^° to 46^°F [2^° to 8^°C]) before and after it is mixed. Do not freeze.Once Humatrope has been mixed and is in liquid form, cartridges must be used within 28 days. Throw away any unused Humatrope in a cartridge after 28 days. Before giving an injection, check the manufacturer's expiration date on the cartridge. Do not use the cartridge if it has expired.

Humatrope is available by prescription only.

HG CON ISI 09JUL2025

See Full Prescribing Information and Instructions for Use.

INDICATIONS

Humatrope^® (somatropin) for injection is used to treat children who are short or growing slowly because they:

Do not make enough growth hormone on their own
Have Turner syndrome
Have idiopathic short stature, which means they are shorter than 98.8% of other children of the same age and sex, are growing at a rate not likely to allow them to reach normal adult height
Have SHOX deficiency
Were born smaller than normal for the number of weeks of pregnancy and do not catch up in height by 2 to 4 years of age

Humatrope is used to treat adults who have growth hormone deficiency.